-- ResMed (RMD) has an average rating of overweight and mean price target of $286.27 according to analysts polled by FactSet.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
Price: $201.18, Change: $-12.57, Percent Change: -5.88%